NO DETECTABLE RESISTANCE TO BULEVIRTIDE MONOTHERAPY THROUGH 96 WEEKS TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS D

被引：0

作者：

Aleman, Soo ^{[1
]}

Liu, Yang ^{[2
]}

Xu, Simin ^{[2
]}

Chang, Silvia ^{[2
]}

Martin, Ross ^{[2
]}

Aeschbacher, Thomas ^{[2
]}

May, Lindsey ^{[2
]}

Manhas, Savrina ^{[2
]}

Han, Dong ^{[2
]}

Yazdi, Tahmineh ^{[2
]}

Martinez, Clarissa ^{[2
]}

Ho, Pui Yan ^{[2
]}

Richards, Christopher ^{[2
]}

Marceau, Caleb ^{[2
]}

Manuilov, Dmitry ^{[2
]}

Flaherty, John F. ^{[2
]}

Maiorova, Evguenia ^{[2
]}

Mo, Hongmei ^{[2
]}

Wedemeyer, Heiner ^{[3
]}

Lampertico, Pietro ^{[4
]}

机构：

[1] Karolinska Inst, Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden

[2] Gilead Sci Inc, Foster City, CA 94404 USA

[3] Hannover Med Sch, Hannover, Germany

[4] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1237-C

引用

页码：S398 / S399

页数：2

共 50 条

[1] No detectable resistance to bulevirtide in participants with chronic hepatitis D (CHD) through 24 weeks of treatment
Hollnberger, Julius
Liu, Yang
Martin, Ross
Manhas, Savrina
Aeschbacher, Thomas
Chang, Silvia
Xu, Simin
Han, Bin
Yazdi, Tahmineh
May, Lindsey
Han, Dong
Schoeneweis, Katrin
Flaherty, John F.
Suri, Vithika
Manuilov, Dmitry
Mateo, Roberto
Svarovskaia, Evguenia S.
Mo, Hongmei
Urban, Stephan
JOURNAL OF HEPATOLOGY, 2022, 77 : S845 - S845
[2] No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
Hollnberger, Julius
Liu, Yang
Xu, Simin
Chang, Silvia
Martin, Ross
Manhas, Savrina
Aeschbacher, Thomas
Han, Bin
Yazdi, Tahmineh
May, Lindsey
Han, Dong
Shornikov, Alex
Flaherty, John
Manuilov, Dmitry
Suri, Vithika
Asselah, Tarik
Lampertico, Pietro
Wedemeyer, Heiner
Aleman, Soo
Richards, Christopher
Mateo, Roberto
Maiorova, Evguenia
Cihlar, Tomas
Mo, Hongmei
Urban, Stephan
JOURNAL OF HEPATOLOGY, 2023, 79 (03) : 657 - 665
[3] NO RESISTANCE TO TENOFOVIR ALAFENAMIDE DETECTED THROUGH 96 WEEKS OF TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B
Chan, Henry Lik-Yeun
Marcellin, Patrick
Cathcart, Andrew L.
Bhardwaj, Neeru
Flaherty, John F.
Gaggar, Anuj
Izumi, Namiki
Lim, Young-Suk
GUT, 2018, 67 : A96 - A97
[4] No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B
Chan, Henry Lik-Yuen
Marcellin, Patrick
Pan, Calvin Q.
Cathcart, Andrea L.
Bhardwaj, Neeru
Liu, Yang
Cox, Stephanie
Parhy, Bandita
Zhou, Eric
Flaherty, John F.
Miller, Michael D.
Gaggar, Anuj
Shalimar
Izumi, Namiki
Lim, Young-Suk
HEPATOLOGY, 2017, 66 : 11A - 11A
[5] No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection
Cathcart, Andrea L.
Chan, Henry Lik-Yuen
Bhardwaj, Neeru
Liu, Yang
Marcellin, Patrick
Pan, Calvin Q.
Shalimar
Buti, Maria
Cox, Stephanie
Parhy, Bandita
Zhou, Eric
Martin, Ross
Chang, Silvia
Lin, Lanjia
Flaherty, John F.
Kitrinos, Kathryn M.
Gaggar, Anuj
Izumi, Namiki
Lim, Young-Suk
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
[6] SIMILAR RATES OF BIOCHEMICAL RESPONSE ARE OBSERVED ACROSS VIROLOGIC RESPONSE CATEGORIES OVER 96 WEEKS OF BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA
Lampertico, Pietro
Asselah, Tarik
Chulanov, Vladimir
Bogomolov, Pavel
Stepanova, Tatyana
Cornberg, Markus
Manuilov, Dmitry
Li, Mingyang
Lau, Audrey
Da, Ben
Tedesco, Dana
Chee, Grace
Brunetto, Maurizia
Zeuzem, Stefan
Zoulim, Fabien
Wedemeyer, Heiner
Aleman, Soo
HEPATOLOGY, 2024, 80 : S131 - S132
[7] Similar Rates of Biochemical Response Are Observed Across Virologic Response Categories Over 96 Weeks of Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta
Lampertico, P.
Asselah, T.
Chulanov, V.
Bogomolov, P.
Stepanova, T.
Cornberg, M.
Manuilov, D.
Li, M.
Lau, A. H.
Da, B. L.
Tedesco, D.
Chee, G. M.
Brunetto, M. R.
Zeuzem, S.
Zoulim, F.
Wedemeyer, H.
Aleman, S.
DIGESTIVE AND LIVER DISEASE, 2025, 57 : S57 - S58
[8] Continued treatment of early non-responder or partial virologic responders with bulevirtide monotherapy in patients with chronic hepatitis D through week 96 leads to improvement in virologic and biochemical responses
Lampertico, Pietro
Wedemeyer, Heiner
Brunetto, Maurizia
Bogomolov, Pavel
Stepanova, Tatyana
Ciesek, Sandra
Berger, Annemarie
Manuilov, Dmitry
An, Qi
Lau, Audrey
Da, Ben
Flaherty, John F.
Mercier, Renee-Claude
Zeuzem, Stefan
Cornberg, Markus
Buti, Maria
Aleman, Soo
JOURNAL OF HEPATOLOGY, 2023, 78 : S113 - S114
[9] No Resistance to Tenofovir Disoproxil Fumarate Through 96 Weeks of Treatment in Patients With Lamivudine-Resistant Chronic Hepatitis B
Corsa, Amoreena C.
Liu, Yang
Flaherty, John F.
Ben Mitchell
Fung, Scott K.
Gane, Edward
Miller, Michael D.
Kitrinos, Kathryn M.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) : 2106 - U393
[10] HIGH RATES OF ADHERENCE TO BULEVIRTIDE MONOTHERAPY FOR CHRONIC HEPATITIS DELTA THROUGH 96 WEEKS: RESULTS FROM AN INTERIM ANALYSIS OF THE PHASE 3 STUDY MYR301
Aleman, Soo
Wedemeyer, Heiner
Brunetto, Maurizia R.
Blank, Antje
Andreone, Pietro
Bogomolov, Pavel
Chulanov, Vladimir
Mamonova, Nina
Geyvandova, Natalia
Morozov, Viacheslav
Sagalova, Olga
Stepanova, Tatyana V.
Da, Ben
Manuilov, Dmitry
Chee, Grace
Li, Mingyang
Lau, Audrey H.
zur Wiesch, Julian Schulze
Cornberg, Markus
Zeuzem, Stefan
Lampertico, Pietro
GASTROENTEROLOGY, 2024, 166 (05) : S1603 - S1604

← 1 2 3 4 5 →